TRPV4 and atherosclerosis: In summary, the present study demonstrates that GSK1016790A, a specific and potent small-molecule activator of mechanosensitive ion channel TRPV4, induces eNOS phosphorylation and activation, and inhibits leukocyte adhesion to endothelium and the eventual development of atherosclerosis in mice.